Reversible inhibition of human acetylcholinesterase by methoxypyridinium species

  • Joseph J. Topczewski
  • , Alexander M. Lodge
  • , Sumana N. Yasapala
  • , Maurice K. Payne
  • , Pedrom M. Keshavarzi
  • , Daniel M. Quinn

Research output: Contribution to journalArticlepeer-review

Abstract

The irreversible inhibition of acetylcholinesterase (AChE) by organophosphorous chemical warfare agents necessitates that antidotes be administered for effective treatment. Currently no antidote is known that resurrects the phosphyl-AChE complex once aging has occurred. This report characterizes the affinities of over 30 new AChE inhibitors which could act as resurrecting agents for the aged AChE-OP adduct.

Original languageEnglish (US)
Pages (from-to)5786-5789
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number21
DOIs
StatePublished - Nov 1 2013

Bibliographical note

Funding Information:
This work was supported by the CounterACT Program, National Institutes of Health Office of the Director, and the National Institute of Neurological Disorders and Stroke, Grant 5 R21 NS076430. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Keywords

  • 2-Methoxypyridinium compounds
  • Acetylcholinesterase
  • Reversible inhibition

Fingerprint

Dive into the research topics of 'Reversible inhibition of human acetylcholinesterase by methoxypyridinium species'. Together they form a unique fingerprint.

Cite this